AQS.V - Aequus Pharmaceuticals Inc.

TSXV - TSXV Delayed Price. Currency in CAD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2018-12-30
2017-12-30
2016-12-30
Total Revenue
1,334
1,410
1,139
702
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
257
527
895
1,128
Selling General and Administrative
3,618
3,691
4,063
4,437
Total Operating Expenses
3,874
4,218
5,052
5,565
Operating Income or Loss
-2,540
-2,808
-3,913
-4,864
Interest Expense
-
-
-
-
Total Other Income/Expenses Net
0
-1
18
-2
Income Before Tax
-2,738
-2,804
-3,882
-4,863
Income Tax Expense
-
-
0
-51
Income from Continuing Operations
-2,738
-2,804
-3,882
-4,812
Net Income
-2,738
-2,804
-3,882
-4,812
Net Income available to common shareholders
-2,738
-2,804
-3,882
-4,812
Reported EPS
Basic
-
-0.04
-0.06
-0.10
Diluted
-
-0.04
-0.06
-0.10
Weighted average shares outstanding
Basic
-
75,642
67,897
47,454
Diluted
-
75,642
67,897
47,454
EBITDA
-
-2,620
-3,725
-4,691